Zealand Pharma A/S (CO:ZEAL) — Stock Price

Dkr326.00 DKK
▼ -1.51% today

Zealand Pharma A/S (CO:ZEAL) is currently trading at Dkr326.00 DKK, down 1.51% today. Over the past 52 weeks, shares have ranged between Dkr234.90 and Dkr545.80. This page tracks Zealand Pharma A/S's live share price on the CO exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Zealand Pharma A/S stock valuation.

Zealand Pharma A/S (ZEAL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Zealand Pharma A/S's daily closing share price and trading volume on the CO exchange over the past year, giving a clear view of recent price momentum and liquidity.

Zealand Pharma A/S Income Statement — Revenue, Profit & Earnings by Year

Zealand Pharma A/S's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Dkr9.21 Billion Dkr62.69 Million Dkr342.79 Million Dkr103.99 Million Dkr292.57 Million
Cost of Revenue Dkr28.19 Million Dkr7.87 Million Dkr19.17 Million Dkr30.71 Million Dkr118.81 Million
Gross Profit Dkr9.19 Billion Dkr54.82 Million Dkr323.61 Million Dkr73.28 Million Dkr173.75 Million
Research & Development Dkr1.58 Billion Dkr919.87 Million Dkr684.90 Million Dkr614.04 Million Dkr588.45 Million
SG&A Dkr160.51 Million Dkr73.80 Million Dkr274.24 Million Dkr260.99 Million
Total Operating Expenses Dkr2.03 Billion Dkr1.33 Billion Dkr895.85 Million Dkr920.59 Million Dkr1.22 Billion
Operating Income Dkr7.16 Billion Dkr-1.27 Billion Dkr-572.24 Million Dkr-816.60 Million Dkr-1.05 Billion
EBITDA Dkr7.18 Billion Dkr-1.02 Billion Dkr-651.58 Million Dkr-884.88 Million Dkr-729.68 Million
EBIT Dkr7.16 Billion Dkr-1.04 Billion Dkr-676.67 Million Dkr-915.59 Million Dkr-754.80 Million
Interest Expense Dkr37.70 Million Dkr40.90 Million Dkr28.98 Million Dkr56.45 Million Dkr4.09 Million
Income Before Tax Dkr7.00 Billion Dkr-1.08 Billion Dkr-708.87 Million Dkr-972.04 Million Dkr-1.03 Billion
Income Tax Expense Dkr546.06 Million Dkr-4.62 Million Dkr-5.13 Million Dkr-6.43 Million Dkr-8.79 Million
Net Income Dkr6.46 Billion Dkr-1.08 Billion Dkr-703.74 Million Dkr-965.61 Million Dkr-1.02 Billion

Zealand Pharma A/S Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Zealand Pharma A/S's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Dkr16.46 Billion Dkr9.51 Billion Dkr1.98 Billion Dkr1.54 Billion Dkr2.07 Billion
Total Current Assets Dkr15.67 Billion Dkr8.53 Billion Dkr1.78 Billion Dkr1.32 Billion Dkr1.72 Billion
Cash & Equivalents
Short-term Investments Dkr10.53 Billion Dkr7.75 Billion Dkr1.18 Billion Dkr108.61 Million Dkr299.04 Million
Net Receivables Dkr319.69 Million Dkr138.97 Million Dkr122.36 Million Dkr137.22 Million Dkr153.45 Million
Inventory Dkr10.70 Million Dkr7.93 Million Dkr1.29 Million Dkr118.44 Million
Property, Plant & Equipment Dkr165.49 Million Dkr221.45 Million
Goodwill
Total Liabilities Dkr1.63 Billion Dkr888.86 Million Dkr387.15 Million Dkr723.89 Million Dkr1.14 Billion
Total Current Liabilities Dkr664.97 Million Dkr403.47 Million Dkr284.58 Million Dkr195.49 Million Dkr334.32 Million
Long-term Debt Dkr285.33 Million Dkr0.00 Dkr320.74 Million Dkr647.91 Million
Net Debt Dkr-4.09 Billion Dkr-88.55 Million Dkr-330.08 Million Dkr-625.76 Million Dkr-341.67 Million
Total Stockholder Equity Dkr14.83 Billion Dkr8.62 Billion Dkr1.59 Billion Dkr815.91 Million Dkr927.80 Million
Retained Earnings Dkr6.29 Million Dkr-6.16 Billion Dkr-4.89 Billion Dkr-4.17 Billion Dkr-3.31 Billion

Zealand Pharma A/S Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Zealand Pharma A/S generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Dkr6.53 Billion Dkr-930.82 Million Dkr-425.67 Million Dkr-942.21 Million Dkr-1.21 Billion
Capital Expenditures Dkr33.37 Million Dkr13.15 Million Dkr23.75 Million Dkr11.71 Million Dkr22.13 Million
Free Cash Flow Dkr6.50 Billion Dkr-943.96 Million Dkr-449.42 Million Dkr-953.92 Million Dkr-1.23 Billion
Investing Cash Flow Dkr-2.25 Billion Dkr-7.33 Billion Dkr-1.09 Billion Dkr281.26 Million Dkr-18.12 Million
Financing Cash Flow Dkr-378.18 Million Dkr8.29 Billion Dkr907.01 Million Dkr587.40 Million Dkr1.33 Billion
Dividends Paid Dkr647.91 Million
Stock-Based Compensation Dkr87.03 Million Dkr61.43 Million Dkr52.29 Million Dkr53.50 Million
Depreciation Dkr27.37 Million Dkr25.85 Million Dkr25.09 Million Dkr117.96 Million Dkr40.25 Million
Change in Cash Dkr4.10 Billion Dkr30.99 Million Dkr-619.92 Million Dkr-59.87 Million Dkr168.88 Million

Zealand Pharma A/S Earnings History — EPS Actual vs. Analyst Estimates

Track Zealand Pharma A/S's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 19, 2026 -8.17
Nov 12, 2025 -5.75 -10.42 +44.82%
Aug 14, 2025 105.61 109.53 -3.58%
May 08, 2025 -4.75 -0.64 -642.19%
Feb 20, 2025 -4.12 -4.29 +3.96%
Nov 07, 2024 -3.77 -3.47 -8.65%
Aug 15, 2024 -4.67 -3.98 -17.34%
May 16, 2024 -3.71 -4.20 +11.67%